Arteether toxicokinetics and pharmacokinetics in rats after 25 mg/kg/day single and multiple doses

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 3, 1999, Pages 213-223

  Li, Qigui G ^a   Brueckner, R P ^a   Peggins, J O ^b   Trotman, K M ^a   Brewer, T G ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

Arteether; Multiple doses; Pharmacokinetics; Rats; Toxicokinetics

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; ARTELINIC ACID; ARTESUNATE; DIHYDROARTEMISININ;

ANIMAL EXPERIMENT; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTOXICITY; NONHUMAN; RAT;

EID: 0033369819     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190023     Document Type: Article

References (35)

1. Brewer T.G., Grate S.J., Peggins J.O. et al. (l994) : Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg., 51: 251-259.
2. Petras J.M., Kyle D.E., Ngampochjana M. et al. (1994) : Arteether induced brainstem injury in macaca mulatta. Am. J. Trop. Med. Hyg., 51 (Suppl.): 100.
3. Petras J.M., Kyle D.E., Ngampochjana M. et al. (1997) : Arteether: risks of two-week administration in macaca mulatta. Am. J. Trop. Med. Hyg., 57: 390-396.
4. Genovese R.F., Newman D.B., Li Q-G., Peggins J.O., Brewer T.G. (1998) : Dose-dependent brainstem neuropathology following repeated arteether administration in rats. Brain Res. Bull., 45: 199-202.
5. Brewer T.G., Petras J.M., Peggins J.O. et al. (1993) : Differential neurotoxicity of artemisinin analogs in an in vivo model. Am. J. Trop. Med. Hyg., 49 (Suppl.): 292.
6. Kamchonwongpaisan S., McKeever P., Hossler P., Ziffer H., Meshnick S.R. (1997) : Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg., 56: 7-12.
7. Scientific working group on the chemotherrapy of malaria special programme for research and training in tropical diseases, WHO. (1993) : Arteether Injection. 1993 Investigator's Brochure , Annex H, H3-H7
8. Li Q-G., Brewer T.G., Peggins J.O. (1998) : Anorectic toxicity of dihydroartemisinin, artemether and arteether in rats following multiple intramuscular doses. Int. J. Toxicol., 17: 322-336.
9. Kar K., Shankar G., Bajpai R., Dutta G.P., Vishwakarma R.A. (1988) : Artemisinin: a potent antimalarial agent, general pharmacological properties. Ind. J. Parasitol., 12: 209-212.
10. Yang G.C., Shi W.Z., Li R., Jun G. (1982) : The antimalarial and toxic effect of artesunate on animal models. J. Trad. China Med., 2: 99-103.
11. Kar K., Nath A., Bajpai R., Dutta G.P., Vishwakarma R.A. (1989) : Pharmacology of α/β arteether - a potential antimalarial drug. J. Ethnopharmacol., 27: 297-305.
12. Qang D., Lin X. (1983) : Effect of qinghaosu (artemisinin) suspension in oil on ultrastructure of myocardium in rhesus monkeys. Acta Pharmacol. Sin., 4: 191-194.
13. Chen L., Wang M., Sun W., Liu M. (1984) : Embryotoxicity and teratogenicity studies on artemether in mice, rats and rabbits. Acta Pharmacol. Sin., 5: 118-122.
14. Wang T. (1989) : Follow-up observation on the therapeutic effects and remote reactions of artemisinin (qinghaosu) and artemether in treating malaria in pregnant woman. J. Trad. China Med., 9: 28-30.
15. Myint P.T., Shwe T. (1986) : The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma. Southeast Asian. J. Trop. Med. Public Health, 17: 19-22.
16. Myint P.T., Shwe T. (1987) : A controlled clinical trial of artemether (qinghaosu derivative) versus quinine in complicated and severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 81: 559-561.
17. Li G.Q. (1992) : Clinical trials on artemisinin and its derivatives in treatment of malaria in China. In: Tharavanij S. et al. (eds) 13th International Congress for Tropical Medicine and Malaria. Abstract 1, 68-69.
18. Kager P.A., Schultz M.J., Zijlstra E.E., van den Berg B., van Boxtel Ch.J. (1994): Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance. Trans. R. Soc. Trop. Med. Hyg., 88: S1/53-54.
19. China Cooperative research group on qinghaosu and its derivatives as antimalarials. (1982) : Studies on the toxicity of qinghaosu and its derivatives. J. Trad. China Med., 2: 31-38.
20. China Cooperative research group on qinghaosu and its derivatives as antimalarials. (1982): Clinical studies on the treatment of malaria with qinghaosu and its derivatives. J. Trad. China Med., 2: 45-50.
21. Valecha N., Gupta S. et al. (1997) : Efficacy of alpha,beta-arteether in acute uncomplicated P. falciparum malaria. Int. J. Clin. Pharmacol. Res., 17: 11-15.
22. White N.J. (1994) : Artemisinin: current status. Trans. R. Soc. Trop. Med. Hyg., 88 (Suppl. 1): S1/3-4.
23. Nicolosi R.J., Tao L.F., Coleman R.M. (1994) : Effect of artemisinin derivative-arteether against experimental schistosomiasis. Am. J. Trop. Med. Hyg., 51 (Suppl.): 194.
24. Li Q-G., Peggins J.O., Fleckenstein L.L., Masonic K., Heiffer M.H., Brewer T.G. (1998) : The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J. Pharmacy Pharm., 50: 173-182.
25. National Research Council (NRC). (1996) : Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources Commission on Life Sciences, NRC. Washington, DC, National Academy Press, 21-55.
26. Nichols M.B., Maickel R.P. (1989) : Amphetamine enantiomers and rat consummatory behavior: A new perspective. Pharmacol. Biochem. Behav., 33: 181-188.
27. Sakata T., Fukushima K., Tsutsui K., Arase K., Fujimoto K. (1982) : Theophylline disrupts diurnal rhythms of humoral factors with loss of meal cyclicity. Physiol. Behav., 28: 641-647.
28. Gibaldi M., Perrier D. (1982) : Multicompartment Models in Pharmacokinetics, New York, Marcel Dekker, 34-55.
29. Rowland M., Tozer T.N. (1995) : Clinical Pharmacokinetics: Concepts and applications. Rowland M., Thomas N. (eds). Tozer, Baltimore, USA: Willianms & Wilkins, 53-105
30. Klayman D.L. (1985) : Qinghaosu (artemisinin): an antimalarial drug from China. Science, 228: 1049-1055.
31. Brossi A., Venugopalan B., Gerpe L.D. et al. (1988) : Arteether, a new antimalarial drug; synthesis and antimalarial properties. J. Med. Chem., 31: 645-650.
32. Shargel L., Yu A.B.C. (1993) : Applied Biopharmaceutics and Pharmacokinetics. Norwalk, CN: Appleton & Lange, 353-374
33. Rangan U., Hedli C., Gallo M., Lioy P., Snyder R. (1997) : Exposure and risk assessment with respect to contaminated soil: significance of biomarkers and bioavailability. Int. J. Toxicol, 16:419-432.
34. Hanson D.J. (1961) : Local toxic effects of broad-spectrum antibiotics following injection. Antibiot. Chemother., 11: 390-404.
35. Svendsen O. (1982) : Local muscle damage and oily vehicles: a study on local reactions in rabbits after intramuscular injection of neuroleptic drugs in aqueous or oily vehicles. Acta Pharmacol. Toxicol., 52: 298-304.